v3.25.2
Investments (Tables)
6 Months Ended
Jun. 30, 2025
Investments [Abstract]  
Schedule Of Long Term Investments

The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2025 and year ended December 31, 2024:

 

 

 

June 30, 2025

 

December 31, 2024

 

 

(in thousands)

Beginning

$

43,578

$

64,361

Additions

 

400

 

12,029

Proceeds

 

(50)

 

(29,824)

Fair value adjustment

 

50

 

(2,988)

Transfers and other

 

(142)

 

Ending

$

43,836

$

43,578

Schedule of Change in Fair Value of Company's Investments

The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments recorded during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Equity Investments

$

$

(481)

 

$

$

158

Notes Receivable Instruments

 

 

9

 

 

 

9

Accrued Interest on Notes Receivable Instruments

 

25

 

84

 

 

50

 

167

Net fair value gains (losses)

$

25

$

(388)

 

$

50

$

334

Schedule of equity investments

The following table summarizes the change in the Company's Level 1 equity investments during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Beginning

$

$

2,499

 

$

$

2,001

Proceeds

 

 

(1,512)

 

 

 

(1,652)

Fair value adjustment

 

 

(481)

 

 

 

158

Transfers and other

 

 

1

 

 

 

Ending

$

$

507

 

$

$

507

 

On July 17, 2024, the Company sold all remaining Level 1 equity investments. As of June 30, 2025, the Company held no Level 1 equity investments.

The following table summarizes the change in the Company's Level 3 equity investments during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Beginning

$

36,487

$

25,953

 

$

36,487

$

25,953

Additions

 

400

 

 

 

400

 

Ending

$

36,887

$

25,953

 

$

36,887

$

25,953

Schedule of unrealized (losses) gains associated equity investments

The following table summarizes unrealized (losses) gains recognized on the Company's equity investments held during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Net unrealized (losses) gains on equity investments

$

$

(253)

 

$

 $

319

Schedule of notes receivable instrument investments

The following table summarizes the change in the Company's Level 1 note receivable instrument during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Beginning

$

$

22,214

 

$

$

22,214

Additions

 

 

1,965

 

 

 

1,965

Fair value adjustment

 

 

9

 

 

 

9

Ending

$

$

24,188

 

$

$

24,188

The following table summarizes the change in the Company's Level 3 notes receivable instruments during the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

 

2025

 

2024

 

(in thousands)

Beginning

$

6,974

$

10,181

 

$

7,091

$

14,193

Additions

 

 

500

 

 

 

1,000

Proceeds

 

(50)

 

 

 

(50)

 

(4,596)

Accrued Interest

 

25

 

84

 

 

50

 

167

Transfers and other

 

 

(1)

 

 

(142)

 

Ending

$

6,949

$

10,764

 

$

6,949

$

10,764